Home > Equine Direct > EQ Vaccines > Rhino (Rhinopneumonitis) >   Calvenza EHV
Calvenza EHV

For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4). Item# Item Name Our Price Qty Add 802-BICEHV10 Calvenza EHV 10 dose $97.99 802-BICEHV1 Calvenza EHV 10x1 $114.99 802-023616 Calvenza EHV single dose $11.99 Check the items you wish to purchase, then click Features: Unique EHV-1 equine respiratory origin isolate. Stimulates antibody to EHV-1 & EVH-4. Proven efficacious against EHV-1 & EHV-4 in challenge studies. Novel adjuvant. Safe, all killed vaccine. Includes innovative pliable nasal applicator. Technical Specs: Dosage & Administration Using aseptic technique inoculate horses IM with a 2 mL dose. Administer a second 2 mL dose IM in 3-4 weeks using a different injection site. Administer a third 2 mL dose in 3-4 weeks either IM or IN. Revaccinate annually and prior to anticipated exposure, either IM or IN. Precautions Store at a temperature between 35�� - 45�� F (2�� - 7�� C). Protect from freezing. Shake well before using. Do not vaccinate within 21 days of slaughter. Antidote: Epinephrine. Uses For the vaccination of healthy, susceptible horses 6 months of age or older, including pregnant mares, as an aid in the reduction of respiratory disease due to equine herpesvirus type 1 (EHV-1) and type 4 (EHV-4). Warning This product has been tested under laboratory conditions and shown to meet all Federal standards for safety and efficacy in normal, healthy, immunocompetent animals. This level of performance may be affected by conditions such as stress, weather, nutrition, disease, parasitism, other treatments, individual idiosyncrasies or impaired immunological competency. These factors should be considered by the user when evaluating product performance or freedom from reactions. Extended Information: Aids in reduction of respiratory disease caused by EHV-1 & EHV-4. Flexible dose administration. No reversion to virulence concern. Minimal vaccine site reactions. Three dose regimen conforms to AAEP recommendations.   Calvenza EHV is proven safe. Calvenza EHV is proven effective by challenge.

 Share your knowledge of this product with other customers... Be the first to write a review.

Browse for more products in the same category as this item: Equine Direct > EQ Vaccines > Rhino (Rhinopneumonitis)